Viewing Study NCT04482257


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-31 @ 2:26 AM
Study NCT ID: NCT04482257
Status: UNKNOWN
Last Update Posted: 2020-07-22
First Post: 2020-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module